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Abstract
The in vitro cell tests and in vivo animal tests were performed to investigate the feasibility of the photothermal
therapy based on porous silicon (PSi) in combination with near-infrared (NIR) laser. According to the Annexin V-
fluorescein isothiocyanate Apoptosis assay test results, the untreated cells and the cells exposed to NIR laser
without PSi treatment had a cell viability of 95.6 and 91.3%, respectively. Likewise, the cells treated with PSi but not
with NIR irradiation also had a cell viability of 74.4%. Combination of these two techniques, however, showed a cell
viability of 6.7%. Also, the cell deaths were mostly due to necrosis but partly due to late apoptosis. The in vivo
animal test results showed that the Murine colon carcinoma (CT-26) tumors were completely resorbed without
nearly giving damage to surrounding healthy tissue within 5 days of PSi and NIR laser treatment. Tumors have not
recurred at all in the PSi/NIR treatment groups thereafter. Both the in vitro cell test and in vivo animal test results
suggest that thermotherapy based on PSi in combination with NIR laser irradiation is an efficient technique to
selectively destroy cancer cells without damaging the surrounding healthy cells.
Introduction
In recent years, photothermotherapy (PTT) techniques
based on inorganic nanomaterials and near-infrared
(NIR) light have attracted significant attention owing to
their advantages over conventional surgical treatments.
The advantages of PTT include the anticipated reduc-
tion in morbidity and mortality, low cost, suitability for
real-time imaging guidance, and the ability to perform
ablative procedures on outpatients because of its non-
invasive nature [1]. In the conventional PTTs based on
simple heating, i.e., hyperthermia [[2], and references
therein], most treatment failures result from insufficient
temperature rises in the tumor tissues. Therefore, it is
essential to use a thermal coupling agent with a good
photothermal property to secure irreversible destruction
of tumor cells in a short time without damaging adja-
cent healthy cells in thermotherapy.
The inorganic nanomaterials currently demonstrated as
thermal coupling agents in PTTs are gold nanoparticles
(Au NPs) [3-12], gold nanorods [13-16], gold nanoshells
[1,17-19], gold nanocages [20,21], gold nanocrystals
[22,23], single wall carbon nanotubes (SWCNTs) [24-26],
and porous silicon (PSi) [27,28]. Of these nanomaterials,
we are particularly interested in PSi because it is known
to have many important properties such as biocompat-
ibility [29], biodegradability [30,31], and a readily functio-
nalized surface [32] which a therapeutic agent should
have desirably as well as an excellent photothermal prop-
erty [33]. In addition, PSi has a merit that it can be easily
prepared by the simple electrochemical anodization of
silicon. As regards biomedical applications of PSi, their
use in drug delivery [34-39] and photodynamic therapy
[40-42] applications have been reported before. We pre-
viously reported on the excellent heat generation ability
of PSi and the ability of PSi to irreversibly destroy cancer
cells under NIR laser irradiation by using temperature
rise measurement and MTT assay results, respectively
[27,28]. In this paper, we report the Annexin V-fluores-
cein isothiocyanate (FITC) apoptosis assay test and in
vivo animal test results of PSi in combination with NIR
laser to investigate the ability of PSi to kill cancer cells as
well as the death modes of cancer cells and the ability of
PSi to inhibit the growth of tumors, respectively.
Experimental details
Preparation of PSi/EtOH:PEG drug solutions
First, meso-PSi layers were prepared on 2.5 cm × 2.5 cm
× 0.05 cm pieces of p-type Si(100) with a resistivity of
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provided the original work is properly cited.1-5 mΩcm by anodic etching in an 3:1 (by volume) solu-
tion of 46% HF and 95% C2H5OH at a current density of
200 mA/cm
2 for 150 s. PSi is generally classified into
three different types in terms of the pore size: macro-PSi
(d >5 0n m ) ,m e s o - P S i( 2n m< d < 50 nm), micro-PSi
(d < 2 nm). According to our experience, meso-PSi is the
most suitable for photothermotherapy since it shows the
highest photothermal effect and can be easily to be frac-
tured into nanoparticles with proper sizes. The porosity
and thickness of the PSi layers determined by weight
measurements [43] were about 73% and 55 μm, respec-
tively. The details of the anodization process are
described elsewhere [27]. The PSi layers formed on Si
(100) were then lifted off by anodic etching in an 1:15 (by
volume) solution of 46% HF and 95% C2H5OH at a
current density of 4 mA/cm
2 for 250 s. Next, the free-
standing PSi layers were fractured by ultrasonicating in
10 mL of ethanol for 24 h. The PSi nanoparticles were
subsequently filtered twice by using a 450 nm membrane
first and then by using a 220 nm membrane. PSi/EtOH:
PEG drug solutions were prepared by dispersing the
resulting PSi particles in 10 mL of ethanol mixed with
10 mL of thiolated polyethyleneglycol (PEG-SH) and cen-
trifuged for 24 h until all the PSi particles were dispersed.
Measurement of heating of the PSi/EtOH:PEG solution by
NIR irradiation
Heterochromatic NIR light irradiation was performed on
six different samples by using NIR laser. The samples
include a PSi/EtOH:PEG solution and a EtOH:PEG solu-
tion as well as a solid PSi (a free standing PSi layer).
The three different kinds of samples were irradiated
continuously for 20 min by the NIR laser at 1.5 W/cm
2.
The distance between the laser source and each sample
was fixed to be 2 cm. Change in the temperature of the
samples with the NIR exposure time was measured at
30-s intervals by using an IR thermometer (model: AZ
8859, max. output: 1 mW, wavelength: 670 nm, mea-
surement range: -20 to 420°C).
Cells and materials
The Murine colon cancer cell lines (CT-26) were pur-
chased from the Korean Cell Line Bank (KCLB, Seoul,
Korea). CT-26 cells were cultured in Dulbecco’sm o d i -
fied Eagle’s medium (DMEM), supplemented with 10%
fetal bovine serum (FBS) and 1% penicillin/streptomycin.
FBS, cell culture media, penicillin-streptomycin and all
other agents used in cell culture studies were purchased
from Invitrogen™ (GIBCO, NY, USA). Cultures were
maintained at 37°C in a CO2 incubator with a controlled
humidified atmosphere composed of 95% air and 5%
CO2. Trypan blue dyes were purchased from Sigma-
Aldrich (St. Louis, MO, USA).
Annexin V- FITC apoptosis assays
CT-26 cells were cultured in DMEM. The incubations
of 1 × 10
6 CT-26 cells were carried out at 37°C and in
5% CO2 atmosphere for approximately 24 h in 24-well
plates, with the cells having been seeded in a 100 nm
dish for approximately 18 h before incubation. After
incubation, the cell media were removed from the wells,
and the cells were washed using PBS and then incom-
plete DMEM was added to each well. Then, the PSi/
EtOH:PEG solution was added to each well. Annexin V-
FITC apoptosis assays were performed on four different
mouse CT-26 cell sample groups to see the ability of
our technique to irreversibly destroy cells and the
modes of cell deaths: the CT-26 cell control group given
neither PSi nor laser treatment, the CT-26 cell group
not treated with PSi but with laser, the group not trea-
ted with laser but with PSi, the group treated with both
PSi and laser. For the preparation of the last sample
group, CT-26 cells were treated with the PSi/EtOH:PEG
drug solution (0.7 g/L) first and then NIR laser at
600 mW/cm
2 for 20 min. Next, the 2 × 10
6 cells were
removed from the culture, washed twice with cold PBS,
and double-stained with Annexin V-FITC and propi-
dium iodide (PI) (BD Biosciences, San Jose, CA, USA)
in Annexin-binding buffer, followed by analysis on a
FAC-Scalibur flow cytometer (Becton Dickinson, San
Jose, CA, USA) equipped with a 488-nm argon laser. To
avoid nonspecific fluorescence from dead cells, live cells
were gated using forward and side scatter.
Trypan blue cell death assays
Cell viability was performed by the trypan blue cell
death assay. Briefly, CT-26 cells were plated at a density
of 3 × 10
5 cells in 60 mm culture dishes for 24 h. Then,
the medium was removed, and the cells were treated
with a PSi/EtOH:PEG solution to each plate. The final
concentration of ethanol in the medium was ≤0.5% (v/
v). Detached CT-26 cells treated with a PSi/EtOH:PEG
solution were exposed to NIR laser at 600 mW/cm
2 for
20 min. After NIR irradiation, a collection of superna-
tants and adherent cells obtained by trypsinization was
incubated in 0.4% trypan blue and pipetted onto a
hemocytometer and manually counted under a micro-
scope at ×100 magnification. The percentage of cells
admitting trypan blue dye to the total number of cells
was determined by counting three different fields
for each experimental condition, which was done in
triplicates [44].
In vivo animal tests
Animal care and all experimental procedures were con-
ducted in accordance with the Guide for Animal Experi-
ments edited by the Korean Academy of Medical
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6 cells) were sus-
pended in 100 μL PBS, and subcutaneously injected into
t h eb a c ko fm a l em i c eo fe a c hg r o u p( n =5 ,5 -t o
6-week-old, Balb/c). When the tumors were grown up
t oav o l u m eo f6 5 - 7 0m m
3,m i c ew e r er a n d o m i z e di n t o
four groups: (a) mice were simply monitored without
any other treatment; (b) mice were intratumorally
injected with 100 mL of PBS and then irradiated NIR
laser 4 times at 1.5 W/cm
2 for 2 min each time with a
time interval of 2 min under the ether anesthesia; (c) a
PSi/EtOH:PEG solution (0.7 g/L, 100 μL) was intratu-
morally injected without NIR laser irradiation; (d) a PSi/
EtOH:PEG (0.7 g/L, 100 μL) was injected into tumor,
then NIR laser was immediately irradiated on the tumor
region in the same manner as in (a). The mice were
anesthetized by injecting 40 μL of a 9:1 solution of keta-
mine (100 mg/mL) and rompun (100 mg/mL). Tumor
volumes, animal body weights, and tumor conditions
were recorded weekly for the duration of the study [45].
The tumor size of each group was measured using a
skinfold caliper, and tumor volumes were calculated
using the following equation: tumor volume = ab
2/2,
where a is the maximum diameter of tumor and b is
the minimum diameter of tumor [46]. All the proce-
dures for in vivo experiments were performed in accor-
d a n c ew i t hI n h aU n i v e r s i t yo fB i o m e d i c a lS c i e n c e
guidelines on animal care and use.
Results and discussion
Photothermal properties of the PSi/EtOH:PEG solution
The PSi nanoparticles functionalized with PEG were
well solublized, so that they were uniformly distributed
in the PSi/EtOH:PEG solution without forming any
floating particles, precipitates, or agglomerates for a
long period of time as shown Figure 1a. Functionaliza-
tion of PSi with PEG is necessary to enhance the inter-
nalization of PSi particles into cells as well as the
attachment of antibodies to PSi particles for the sys-
tematic administration of cancer. Ethyl alcohol was
also used to enhance the dispersion of PSi nanoparticles
in the solution. Figure 1b displays the size distribution
of the PSi nanoparticles after being filtered by using
a 220 nm membrane, which was in a range from
80-220 nm in diameter with a mean diameter of
approximately 140 nm. The photothermal property was
compared between solid PSi, PSi/EtOH:PEG solution
(0.7 g/L), and EtOH:PEG solution in Figure 2. The
surface temperature of each sample during exposure to
808 nm NIR laser at 1.5 W/cm
2 was measured by using
an IR thermometer. The PSi nanoparticles exhibited a
very rapid increase in temperature for the first 1 min
and a slow increase for the next 5-6 min. The tempera-
ture reached at approximately 70°C in about 6 min
upon NIR laser irradiation and did not nearly changed
thereafter. The net temperature rises shall have been
47°C, taking the temperatures of the PSi film at the
exposure time of 0 min (~23°C) into consideration. This
high photothermal effects in PSi is mainly attributed to
the high absorbance and the high surface-to-volume
ratio due to the numerous micropores in PSi [33]. The
temperature of the PSi/EtOH:PEG solution changed
with the NIR exposure time in a pattern similar to the
solid PSi, but the temperature was much lower than
that of the PSi nanoparticles presumably due to the
absorption of heat by the liquid phases such as EtOH
and PEG in the solution. The temperature difference
between PSi/EtOH:PEG and EtOH:PEG is about 10°C
for the NIR irradiation time larger than 15 min, which
may seem to be somewhat small for thermotherapy. In
the in vivo animal tests, the EtOH:PEG solution injected
directly into tumors would move easily to the whole
body of the mouse. Consequently, a very little amount
of remnant solution would stay in the tumors. In con-
trast, the PSi/EtOH:PEG solution injected directly into
tumors would stay in the tumors for a longer time
because it has a higher viscosity than the simple EtOH:
PEG solution. Therefore, there would be a big difference
between the two solutions in the actual effect of
destroying cancer cells.
Annexin V- FITC apoptosis assay tests
The fluorescent-activated cell sorter (FACS) flow cyto-
metry profiles (Figure 3a-d) obtained as a result of
Annexin V-FITC Apoptosis assay represent Annexin V-
FITC staining in X-axis and PI in Y-axis. The four sec-
tions of the quadrant in each profile from the upper left
in a clockwise direction represent necrosis, late apopto-
sis, early apoptosis, and live cell, respectively. Of these
four kinds of cell modes, necrosis and late apoptosis are
usually considered as cell death. The Annexin V-FITC
Apoptosis assay results in (Figure 3a-d) are summarized
in Figure 3e. The untreated cells and the cells exposed
to NIR laser without PSi treatment had a cell viability of
95.6 and 91.3%, respectively. Likewise, the cells treated
with PSi but not with NIR irradiation also had a cell via-
bility of 74.4%. Combination of these two techniques,
however, showed a cell viability of 6.7%, implying that
most cells are killed. The group treated with both PSi
and NIR laser shows substantially higher cell death
(necrosis + late apoptosis) rate than those not given
both treatments. It can also be seen in Figure 3e that
the cell deaths are mostly due to necrosis but partly due
to late apoptosis. This in vitro cell test result suggests
that only combination of PSi and NIR laser treatments
can kill cells. The viability of 74.4% for the cells treated
with PSi but not with NIR irradiation seems to be low,
suggesting that PSi is somewhat toxic. This toxicity of
PSi may originate from HF residues on the surfaces of
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effort should be made to remove all the HF residues
during the course of PSi nanoparticles preparation.
We previously reported as a result of the in vitro cell
test based on MTT assay that the cell viabilities of the
mouse groups untreated, treated only with PSi, treated
only with laser, and treated with PSi followed by laser
treatment were 99.8, 95.2, 98.1, and 2.6%, respectively
[28]. The present Annexin V-FITC Apoptosis assay
result is somewhat worse than the previous MTT assay
result. In the previous test, the PSi/NaCl suspension was
used instead of the PSi/EtOH:PEG solution as a PSi
drug solution. Another difference is that the PSi concen-
tration in the PSi/NaCl suspension (~10.0 g/L) was far
higher than that in PSi/EtOH:PEG solution (0.7 g/L)
since the PSi was not filtered by using a 220-nm mem-
brane in the former suspension whereas PSi was filtered
prior to the in vitro cell test in the latter solution.
Therefore, the higher cell viability, i.e., the lower cell
death rate of the group treated with both PSi and laser
(a)                               (b)
Figure 1 PSi particle size distribution: (a) PSi/EtOH:PEG solution and (b) the distribution of the diameter of PSi nanoparticles in the PSi/EtOH:
PEG solution.
Figure 2 Comparison of photothermal property between solid PSi, PSi/EtOH:PEG solution (0.7 g/L), and EtOH:PEG solution. ΔT1 and
ΔT2, respectively, in this graph represent the temperature rises in solid PSi (a free-standing PSi layer) and PSi/EtOH:PEG solution upon NIR laser
irradiation at 1.5 W/cm
2.
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PSi concentration in the PSi drug solution.
Trypan blue cell death assay tests
To determine whether the effect of PSi nanoparticles
under the NIR laser irradiation on cells was cytotoxic,
trypan blue cell death assay was performed on mouse
CT-26 cells to investigate localized photothermal
destruction of the cancer cells. High-magnification opti-
cal microscopy images of the cells dispersed in the PSi/
EtOH:PEG solution given the laser treatment is shown
in Figure 4. The cells were first treated with a 0.7 g/L
PSi/EtOH:PEG solution. Next, the cells were exposed to
laser and then stained by trypan blue dye to examine
cell damage. The color of the dead cells usually turns
black after staining treatment. It can be seen in Figure 4
that more than 60% of the cells irradiated with NIR
laser have turned black in color, indicating cell death.
In vivo animal tests
The in vitro cell test results show the photothermal
effect of the thermotherapy based on PSi combined with
laser on cell death, but it does not guarantee that the
thermotherapy can inhibit tumor growth. To confirm
that the photothermal effect of PSi combined with NIR
laser could efficiently destroy tumor cells without giving
damage to surrounding healthy cells, we attempted
in vivo therapeutic examinations against Balb/c mice
bearing (CT-26) on their backs. When the tumors were
grown up to a volume of approximately 100 mm
3,P S i /
EtOH:PEG solution (0.7 g/L, 100 μL) were then injected
directly into the tumor regions. A mouse ready for the
irradiation was located under the focal lens through
which NIR laser could be focused to have a power den-
sity of 1.5 W/cm
2 and irradiated 4 times for 2 min each
time with a time interval of 2 min. This intermittent
Figure 3 Annexin V-FITC Apoptosis assay results: Flow cytometry profiles represent Annexin-V-FITC staining in X-axis and PI in Y-axis:
(a) control, i.e., neither PSi nor laser treatment (control), (b) PSi treatment only, (c) NIR laser treatment only (for 20 min at 600 mW/cm
2), and
(d) PSi treatment (PSi concentration = 0.7 g/L) followed by laser treatment (for 20 min at 600 mW/cm
2). (e) Summary of the Annexin V-FITC
Apoptosis assay results showing the percentages of cell death modes: necrosis, late apoptosis, early apoptosis, and live cell.
Figure 4 Trypan blue staining. Optical microscopic images of the
CT-26 cells treated with a PSi/EtOH:PEG solution (0.7 g/L) followed
by NIR laser treatments (for 20 min at 600 mW/cm
2) 4 times for
2 min each time with a time interval of 2 min. The cells were
stained using trypan blue dye after the NIR laser treatments to
examine cell damage. The cells indicated by arrows are some
examples of dead cells turned blue after staining.
Hong et al. Nanoscale Research Letters 2011, 6:321
http://www.nanoscalereslett.com/content/6/1/321
Page 5 of 8laser irradiation was designed to minimize the damage
of the healthy tissues adjacent to the tumor tissues. As
shown in Figure 5, the mouse treated with a PSi/EtOH:
PEG solution and NIR laser irradiation shows perfect
tumor destruction 25 days after the treatments. It
appears that the tumor has shrinked to almost zero
volume at day 5 post-treatment. The tumescent part
formed on the laser-treated region is not the shrinked
tumor but looks like a kind of water blister formed
by thermal energy from PSi nanoparticles. Finally,
the tumor has completely disappeared at day 25 post-
treatment although the complete disappearance of the
tumor is not clearly observable owing to the regrown
fur. Comparison of the tumor site between the four
groups treated differently, however, more clearly indi-
cates the complete destruction of the tumor in the
group treated both PSi and laser. It is worthy of noting
that the surface structures including the epidermis and
subcutaneous tissue got no damage such as carboniza-
tion at all. It is common that an esker or a black skin
burn mark forms and it falls off many days after treat-
ment in PTT. Even no such marks were observed on
the mice in the group treated both PSi and laser. The
intact surface structures suggest that the treatment para-
meters including the power intensity of the laser and the
PSi concentration of the PSi/EtOH:PEG solution was
adequate. It is well known that the degree of damage of
the surface structures in PTT strongly depends on the
treatment parameters. The mice given both PSi and
laser treatments remained healthy without any recur-
rence of tumors and side effects for more than 3
months. In contrast, the other three groups including
the control group, the group treated only with PSi, and
that treated only with NIR laser show significant growth
of tumors after the treatment. The size of the tumors in
these groups is in a range of 1.1-1.5 cm at day 5 post-
treatment. The tumors grew continuously to be 1.8-2.7
cm in diameter at day 25 post-treatment. The same
kind of in vivo animal tests were repeated for another
two sets of mouse groups and similar results were
obtained, implying that these results are very reproduci-
ble. Figure 6 compares the tumor growth rate between
the four different experimental mouse groups. The
tumors in the mice treated with both PSi and laser
show almost zero volume change, whereas the tumors
in the other three groups continued to grow until they
died (Table 1).
Weight change after laser treatment
One of the important issues in PTT using inorganic nano-
materials is the toxicity of the nanomaterials to the organs
of human body. We investigated the toxicity of PSi on the
organs of mouse bodies by an indirect method of measur-
ing the change in weight after laser treatment. It is widely
accepted that the animals given toxic treatment lose
weight. The body weight of the mouse treated with PSi
followed by laser treatment increased slightly in a pattern
similar to the normal mouse without tumors (Figure 7),
indicating that the mouse continued to mature without
any significant toxic effect. Another important issue in
PTT using inorganic nanomaterials is harmless elimina-
tion of the nanomaterials from the human body in a rea-
sonable period of time. Park et al. [31] reported that the
PSi nanoparticles used for drug delivery accumulated in
Figure 5 In vivo animal test results. Photographs of the tumors of the mice treated differently 24 h after treatment: (a) neither PSi nor laser
treatment (control), (b) PSi treatment only, (c) NIR laser treatment only (NIR laser irradiation 4 times for 2 min at 1.5 W/cm
2 each time with a
time interval of 2 min), and (d) PSi treatment (PSi concentration = 0.7 g/L) followed by laser treatment (for 20 min at 600 mW/cm
2).
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period of 1 week and completely cleared in 4 weeks. The
experiments on this issue are also ongoing in our lab.
Conclusions
The in vitro cell test and in vivo animal test results
were performed to investigate the feasibility of the
photothermal therapy based on PSi in combination
with 808 nm NIR laser. Combination of PSi and NIR
laser treatment techniques shows a substantially higher
cell death rate than only one of these two techniques.
The Murine colon carcinoma (CT-26) tumors were
completely resorbed without nearly giving damage to
surrounding healthy tissue within 5 days of PSi and
NIR laser treatment. All the mice given both treat-
ments remained healthy and free of tumors and side
effects for more than 3 months. The preliminary
results in this work shows the feasibility of photother-
motherapy based on PSi in combination with NIR laser
irradiation in selectively destroying cancer cells without
damaging the surrounding healthy cells. However, the
systematic administration of cancers still remains as a
challenge in this therapeutic approach. The experi-
ments on this issue are under way using tumor
targeting techniques such as functionalization of PSi
with specific antibodies.
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